Abstract:Background: KIAA0101, previously identified as proliferating cell nuclear antigen (PCNA)-associated factor, is overexpressed among almost majority of human cancers and has emerged as an important regulator of tumorigenesis and cancer progression; however, its expression, function and underlying molecular mechanisms in the development of human nasopharyngeal carcinoma (NPC) remain unknown.Methods: Integrated bioinformatics approaches were employed to determine the differentially expressed genes and KIAA0101 expression levels in the NPC samples compared with normal controls by using gene profiling data from GSE6631, GSE12452 and TCGA-HNSC. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the KIAA0101 mRNA expressions in NPC cell lines. PSCSI-GFP lentiviral vectors carrying KIAA0101 short hairpin RNA (shRNA) were constructed and stable transfected cells were then validated by immunofluorescence, qRT-PCR and western blot for further investigating the effect of KIAA0101 on malignant phenotypes of NPC cells. The effect of KIAA0101 on cell proliferation and apoptosis were evaluated by immunofluorescence, MTT, colony formation and flow cytometry. LinkedOmics was also employed to explore the primary biological process and KEGG pathways correlated with KIAA0101. Flow cytometry and Brdu staining were used to investigate the role of KIAA0101 in the process of cell cycle and DNA replication. Mechanistic studies were systematically investigated by UCSC Genome Browser, GEO, UALCAN, transcriptional factors prediction by QIAGEN, PROMO and JASPAR, ChIP, qRT-PCR, and the cBioPortal for Cancer Genomics, et al.Results: The result showed that KIAA0101 ranked top overexpressed gene lists in GSE6631 expression data. KIAA0101 was highly expressed in the NPC or HNSC tissues and NPC cell lines, and higher expression of KIAA0101 was correlated with tumor grade. Furthermore, knockdown of KIAA0101 significantly inhibited NPC cell proliferation and DNA replication, promoted apoptosis and cell cycle arrest in vitro. Meanwhile, the mechanistic study revealed that MAP kinase phosphorylation-dependent activation of the transcription factor ELK1 enhanced neighbor gene expressions of KIAA0101 and TRIP4 by binding both promotor regions in the NPC cells.Conclusions: Taken together, our findings indicate that overexpression of KIAA0101 regulated by MAP kinase phosphorylation-dependent activation of ELK1 plays an important role in NPC development and progression. Targeting KIAA0101 or ELK1 may provide the promising therapeutic potential for NPC treatment.Funding Statement: This work was supported by the Natural Science Foundation of Jiangsu Province (No. BK20150556), Six Talent Peaks Project in Jiangsu Province (No. YY-076), Project funded by China Postdoctoral Science Foundation (No. 2016M603065, No. 2018T111164) and China Jiangsu Planned Projects for Postdoctoral Research Funds (No. 1601159B).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: The study protocol was approved by the Ethics Committee of Medical school of Nanjing University. Data collections and processions were performed according to policies of GEO and TCGA project.

A Positive Feedback Loop Between PLD1 and NF-κB Signaling Promotes Tumorigenesis of Nasopharyngeal Carcinoma

Up-regulation of Polo-like Kinase 1 in Nasopharyngeal Carcinoma Tissues: a Comprehensive Investigation Based on RNA-sequencing, Gene Chips, and In-House Tissue Arrays.

APLNR inhibited nasopharyngeal carcinoma growth and immune escape by downregulating PD-L1

Integrated analysis of bulk and single-cell RNA sequencing reveals the interaction of PKP1 and tumor-infiltrating B cells and their therapeutic potential for nasopharyngeal carcinoma

Phospholipase D as a key modulator of cancer progression

PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation

Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma

Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling

Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma

Role of β-catenin in PD-L1 expression of nasopharyngeal carcinoma

PinX1-Promoted Autophagy Inhibits Cell Proliferation and Induces Cell Apoptosis by Inhibiting the NF-κB/p65 Signaling Pathway in Nasopharyngeal Carcinoma

The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling

Expression and Clinical Significance of Programmed Death Ligand 1 in Nasopharyngeal Carcinoma.

The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α

Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance

PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma

MAPK-ELK1 Signaling Pathway Mediated Overexpression of PCNA-Associated Factor KIAA0101 Controls Cell Proliferation and Apoptosis in Nasopharyngeal Carcinoma: an Integrated Experimental and Bioinformatics Analysis

PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma

Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma

PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load

Combined Upregulation of Matrix Metalloproteinase-1 and Proteinase-Activated Receptor-1 Predicts Unfavorable Prognosis in Human Nasopharyngeal Carcinoma